Captopril administration in pregnancy impairs fetal angiotensin converting enzyme activity and neonatal adaptation.
D000328:Adult; D002216:Captopril / Q000009:adverse effects*; D005260:Female; D005312:Fetal Blood / Q000201:enzymology; D005317:Fetal Growth Retardation / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007231:Infant, Newborn; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011392:Proline / Q000031:analogs & derivatives*
D011392:Proline; D002216:Captopril; D007703:Peptidyl-Dipeptidase A